MAPK3 and melanoma: Cellular localization corresponds to different effects, cytoplasmic BRMS1 appears to restrict tumor progression by negatively affecting cell proliferation, sequestering p-ERK1/2 in the cytoplasm and by preventing accumulation of nuclear p-Akt while nuclear BRMS1 may promote melanoma invasion, perhaps by its association with FABP7.